. (1976). Annals of the Rheumatic Diseases, 35, 487-497. Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage. The anti-inflammatory drugs, sodium salicylate, indomethacin, hydrocortisone, ibuprofen, and flurbiprofen, were examined for their effects on sulphated glycosaminoglycan synthesis in aged human cartilage in vitro. Cartilage was obtained from femoral heads removed during surgery and drug effects were found to vary significantly from one head to another. Statistical analysis of the results showed that sodium salicylate exhibits concentration-dependent inhibition of glycosaminoglycan synthesis over the concentration range used. Indomethacin, hydrocortisone, and ibuprofen, at concentrations comparable to those attained in man, caused a statistically significant depression of sulphated glycosaminoglycan synthesis in cartilage from some femoral heads but not others, reflecting the variable response of human articular cartilage to anti-inflammatory drugs. Sodium salicylate and indomethacin at higher doses produced significant (P<0 005) inhibition of sulphated glycosaminoglycan synthesis in all femoral heads studied. The results for flurbiprofen were less conclusive; this compound appears not to inhibit glycosaminoglycan synthesis over the concentration range used.
An early event in osteoarthrosis is proteoglycan loss from articular cartilage (Mankin, 1974; McDevitt, 1973; Lust and Pronsky, 1972; Bjelle and others, 1972; Mankin and Lipiello, 1970, 1971; Bollet and Nance, 1966; Bollet and others, 1963; Matthews, 1953) . Proteoglycans impart resilience and molecular exclusion properties to cartilage and depletion can result in fibrillation and impaired joint function (Radin and others, 1975; Bullough, Goodfellow, and O'Connor, 1973; Freeman, 1973; Kempson and others, 1970) . In all but severe cases of osteoarthrosis the chondrocyte response to proteoglycan depletion results in an increase in glycosaminoglycan synthesis although the magnitude of this response is debatable (Maroudas, 1975; Mankin and others, 1971 ). An increase in 35SO 4 uptake by osteoarthrotic cartilage chondrocytes as compared to normal chondrocytes was observed autoradiographically as early as 1960 by Collins and McElligott. In the later stages of the disease, when severe damage to the cartilage has Accepted for publication April 25, 1976. Correspondence to Dr. P. Ghosh. occurred, reduced rates of glycosaminoglycan synthesis and chondrocyte death have been reported (Mankin and others, 1971; Mankin and Lipiello, 1970; Collins and McElligott, 1960) .
In animal tissues, including cartilage, antiinflammatory drugs have been reported to inhibit glycosaminoglycan synthesis, both in vivo and in vitro (Bostrom, Bersten, and Whitehouse, 1964; Whitehouse and Bostrom, 1962) . These agents have also been shown to inhibit the synthesis and release of glycosaminoglycans from cultured fibroblasts (Karzel and Domenjoz, 1969;  Kalbhen, Karzel, and Domenjoz, 1967) . Whitehouse (1965) noted that a close correlation exists between anti-inflammatory activity and the inhibition of glycosaminoglycan synthesis in such experimental systems. Osteoarthrosis principally affects the older age groups. In some respects aged human cartilage differs both chemically and metabolically from young animal cartilage (Maroudas, 1975; McDevitt, 1973; Benmaman, Ludoweig, and Anderson, 1969) . Therefore, we have examined the effects of some of the more commonly prescribed anti-inflammatory drugs on the synthesis of sulphated glycosaminoglycans in aged human cartilage, under rigidly controlled culture conditions. Particularly notable was the highly variable response to the drugs of human cartilage from different individuals, highlighting the need for exacting statistical analysis of the results.
Materials and methods

ANTI-INFLAMMATORY DRUGS
The following drugs were obtained in pure form from the manufacturers: indomethacin (Merck, Sharp and Dohme, Rahway, N.J.), sodium salicylate (Nelson Laboratories Pty., Sydney, Australia), ibuprofen and flurbiprofen (Boots, Nottingham, England), hydrocortisone sodium succinate as an injectable preparation (Upjohn Pty., Rydalmere, Australia).
SAMPLING OF ARTICULAR CARTILAGE
Human articular cartilage was obtained from femoral heads removed surgically after subcapital fracture. The ages of the patients ranged from 63 to 83 years. A special tool, holding four parallel razor blades spaced 1 mm apart, was used to cut sections of cartilage 1 mm wide perpendicular to the articular surface. Great care was taken to sample the full depth of articular cartilage since glycosaminoglycan distribution and metabolism is reported to vary with distance from the articular surface (Jones andLemperg, 1975; Maroudas, 1975; Stockwelland Scott, 1967) . For each femoral head, cartilage was sampled from the superior surface which is generally considered to be a weight-bearing area (Maroudas, Evans, and Almeida, 1973) . Each section of cartilage was divided into full-depth slices, 2-3 mm long, for culturing.
CULTURE METHODS
Explants were set up in culture within 2 hours of surgical removal and were maintained in organ culture using a modification of the method of Trowell (1959) . Explants were supported on stainless steel grids, bathed in culture medium 370, ina humidified atmosphere of 5% CO2 in air. The culture medium used was Dulbecco Modified Eagle's Medium supplemented with 10 % fetal calf serum (Commonwealth Serum Laboratories). The serum was found to be essential for maintaining a high level of viability for several days. Under these conditions incorporation of 3H-uridine into RNA, and 85"S4 into glycosaminoglycans (Curran and Gibson, 1956) showed no reduction for at least 3 days, but all experiments were performed within 2 days. The culture methodology will be fully described elsewhere. MEASUREMENT mol/l EDTA and 0 005 mol/l cysteine). Papain digests were dialysed overnight against water and analysed for uronic acid by the method of Bitter and Muir (1962) , and for radioactivity using standard scintillation counting techniques. Incorporation of 35S04 into glycosaminoglycans was expressed as cpm/hg uronic acid.
ANTI-INFLAMMATORY DRUG STUDIES
After cartilage slices had been allowed to stabilize in culture for 1 day, the effects of anti-inflammatory drugs on sulphate incorporation into glycosaminoglycans were studied by incubating cartilage slices in medium containing the drug and 35SO4 at 4) I±Ci/ml. Each drug was studied at three concentrations whose effects on sulphate incorporation were compared to controls with no added drug. The concentrations used covered the range of therapeutic blood plasma levels reported for the drugs examined (Mills and others, 1973; Chalmers and others, 1972; Domenjoz, 1971; Karzel and Domenjoz, 1969; Hucker and others, 1966; Holt and Hawkins, 1965) . However, indomethacin was also examined at higher concentrations. The effect of the drugs was measured over 6 hours, triplicate slices of cartilage being removed from culture at hourly intervals for each drug concentration and the control, making a total of 72 slices for each drug studied. For these experiments, cartilage slices were removed from the stainless steel grids to Falcon Microtest II tissue culture plates (Falcon Plastics, Los Angeles, Calif.), which consist of 96 identical wells. One cartilage slice was incubated in each well in 0-25 ml medium containing 35SO4 and the anti-inflammatory drug. Incubations were terminated by transferring slices into 5 ml ice-cold saline. All drugs dissolved freely in culture medium except indomethacin, which, however, was soluble in medium at approximately pH 9-0, and remained in solution when the pH was readjusted to neutrality.
STATISTICAL ANALYSIS OF RESULTS
The results of each drug experiment, using cartilage from a single femoral head, were analysed by a two-factor (fixed model) analysis of variance (Snedecor and Cochran, 1967) . This type of analysis determines the significance of the effect of the drug in question on the synthesis of sulphated glycosaminoglycans over the time range studied at different drug concentrations. Since each drug was tested using cartilage from more than one femoral head, the significance of the differences between the responses of different femoral heads was determined using a threefactor (mixed value) analysis of variance.
Bartlett's test showed significant heterogeneity of variances (P<0-05) and all data were transformed to natural logarithms to stabilize variances. The results obtained using the statistical methods described are shown in Figs. 1-6 and summarized in Tables I-VI .
Results
INDOMETHACIN
The effect of indomethacin over a concentration range of 0 02-0 005 mmol/l was studied using cartilage from two femoral heads (FH1 and FH2). The effect of the drug on sulphated glycosaminoglycan synthesis differed for the two specimens. One (FH1) showed a significant inhibition of glycosaminoglycan synthesis (P<0 005) with increasing indomethacin concentration. The other (FH2) showed no significant response to the drug ( Fig. 1 ; Table 1 ). When the results for the two femoral heads were analysed together the difference between them was significant (P<0-05). At the higher concentration range (1-0-01 mmol/l), indomethacin was examined for its effect on glycosaminoglycan synthesis using cartilage sampled from three femoral heads (FH3, FH4, and FH5). In each instance a significant depression of sulphated glycosaminoglycan synthesis (P<0 005) was observed with increasing indomethacin concentration ( Fig. 2 ; Table IL ). When the results for the three femoral heads were analysed together the difference between the individual femoral heads was highly significant (P<0.005).
SODIUM SALICYLATE
The effect of sodium salicylate was examined using cartilage from three femoral heads (FH3, FH4, and FH5) and in each case a significant depression of 35SO4 incorporation (P<0-005) was observed with increasing sodium salicylate concentration up to 5-0 mmol/l ( Fig. 3 ; Table III) . As for indomethacin, the difference between individual femoral heads was highly significant (P<0-005). Our preliminary experiments on aged human articular cartilage showed that 98 % ofthe radioactive sulphate taken up during incubation could be removed by simple washing procedures. Of the remaining radioactivity, a further 75 % was removed by dialysis after papain digestion. This latter radioactivity may arise from the storage of 35SO4 in various metabolic pools which may not necessarily be utilized in polymer synthesis at the same time (Lohmander, Antonopoulos, and Friberg, 1973; Rokosova and Bentley, 1973) . A large part of this labelling may also arise from nonspecific binding with preformed matrix, since it occurs at 0°in tissue which has been pre-chilled at this temperature for 30 minutes before incubation with 35SO4, in which biosynthesis would be negligible.
In the present study, 35S04 incorporation into sulphated glycosaminoglycans has been defined in terms of uronic acid content of the tissue after papain digestion and dialysis. The major uronic acid containing glycosaminoglycans in articular Hardingham and Muir (1972) and Davidson and Small (1963) suggests, however, that the turnover rate of this component is low. Hardingham and Muir (1972) , using pig laryngeal cartilage, reported that specific radioactivity measurements based on uronic acid were only slightly modified if the contribution made by keratan sulphate was accounted for. Maroudas (1975) reported preliminary results indicating that the turnover of keratan sulphate is very much slower than that of chondroitin sulphate. Her calculations of total sulphated glycosaminoglycan turnover apply, as do ours, essentially to chondroitin sulphate. Furthermore, the levels of keratan sulphate in human articular cartilage have been reported to remain relatively constant with aging after maturity (Maroudas and others, 1969; Bollet and Nance, 1966) .
The reproducible sampling of the cartilage specimens was of particular importance in the present study. Full-depth samples were taken from the surface to the subchondral bone, as glycosaminoglycan metabolism andconcentration are known tovarywith depth from the surface (Jones and Lemperg, 1975; Maroudas, 1975; Stockwell and Scott, 1967) . Although Maroudas and others (1973) reported that there are only slight variations in glycosaminoglycan content with topographical area for normal femoral heads, Bjelle (1974) did observe variations over the surfaces of femoral condyles. Therefore, where possible, cartilage samples were removed from the same locality. Areas of obvious fibrillation or eburnation were excluded, but were uncommon in normal femoral heads removed after fracture.
In general, the results of our studies on the effects of anti-inflammatory drugs on the metabolism of glycosaminoglycans agree with the literature (Domenjoz, 1971; Whitehouse, 1965 ).
An in vivo autoradiographic study (Watson, 1976 ) with rabbits receiving oral doses of indomethacin showed significant suppression of 3MSO4 uptake by chondrocytes of the femoral condyles. No differences in 35SO4 uptake between animals receiving clinical or higher doses of drug were observed. Our studies were conducted over two concentration ranges, and the response at therapeutic drug levels ( Fig. 1) was less marked than at higher indomethacin doses (Fig. 2) . However, in our experiments, cartilage 2-371: 1-81t slices were exposed to the drug for 6 hours only, whereas Watson investigated the effects of indomethacin for periods of up to 70 days. Roach, Tomblin, and Eyring (1975) , Forney, Bentley, and Mathews (1973) and Simmons and Chrisman (1965) , using morphological and histological techniques, suggested that salicylate stimulates healing of articular cartilage by some biochemical mechanism such as lysosomal stablization or enhancement ofmatrix formation. Salicylates and other anti-inflammatory drugs may protect cartilage by inhibiting the prostaglandin synthetase systems (Moncada, Ferreira, and Vane, 1973; Takeguchi and Sih, 1972; Tomlinson and others, 1972; Vane, 1971 Vane, , 1972 Willis and others, 1972) . Prostaglandins of the E group are now recognized as prime mediators of the inflammatoryresponse (Glenn andothers, 1972; Kaley, Massira, and Weiner, 1972; Willis and others, 1972; Kaley and Weiner, 1971; Arora, Lahiri, and Sanyal, 1970) . Such a protective role would be of greater relevance in the therapy of rheumatoid arthritis than osteoarthrosis where the inflammatory component of the process is far less evident.
The ability of cartilage to function efficiently depends upon its mechanical properties which are an expression of matrix composition and organization. These in turn reflect the balance between synthesis and degradation of its components. The ability of drugs to directly or indirectly moderate joint inflammation and the associated degradative mechanisms accounts for their value in the treatment of rheumatoid arthritis, but not osteoarthrosis. Clearly, the place of some anti-inflammatory agents in the management of degenerative joint diseases should be re-examined in the light of their demonstrated inhibitory effects on cartilage glycosaminoglycan biosynthesis. 
